Company · Healthtech & Bio

ADNTRO Genetics

adntro.com ↗ ·Palma de Mallorca ·Seed

ADNTRO Genetics is a Spanish direct-to-consumer genetics company offering saliva-based DNA testing kits covering ancestry, nutrition, fitness, health risk, and pharmacogenetics, alongside an AI chatbot (GeneAI) for exploring results and a professional-use test (N-GENE) for healthcare providers. Founded in 2019 and headquartered in Palma de Mallorca, it processes samples via Eurofins (Denmark) on Illumina arrays and serves customers in 60+ countries. It is a small seed-stage biotech with roughly 9 employees.

Founded

2019

Founders

News

Rounds

Investors

SectorsConsumer genetics, Personalized medicine, Nutrigenomics, Digital health Start-up MapHealthtech & Bio › Consumer & telehealth services

Profile updated 20 Jul 2026

Founders

Guillermo Pérez-Solero Monzon

CEO & Co-Founder

Jorge Blom-Dahl Oliver

CTO & Co-Founder

Global models 5

23andMe

United States · www.23andme.com ↗

Pioneering direct-to-consumer saliva DNA testing company offering ancestry and health reports, the closest large-scale comparable to ADNTRO's core consumer product.

$944MComparable

Ancestry

United States · www.ancestry.com ↗

Consumer DNA testing kits combined with genealogy records, matching ADNTRO's ancestry-plus-consumer-genomics model.

$446MComparable

Color Health

United States · www.color.com ↗

Genetic testing and preventive/personalized health platform for consumers and clinicians, akin to ADNTRO's professional N-GENE preventive medicine offering.

$378MComparable

Helix

United States · www.helix.com ↗

Population genomics company providing DNA sequencing and health-focused genetic insights through partner products, similar to ADNTRO's health/wellness DNA reporting model.

$435MComparable

MyHeritage

Israel · www.myheritage.com ↗

DNA testing kits paired with ancestry and genealogy services, directly comparable to ADNTRO's ancestry-focused consumer kit.

$49MComparable

Investors 2

Addendum Capital

addendum.capital ↗

Investor Spain

Bio & Tech Smart Capital (Noso Capital)

biotechsmartcapital.com ↗

Investor Spain

Funding rounds 1

Seed · €1M

Bio & Tech Smart Capital FCRE, the venture fund of Noso Capital, invested €1M in Palma-based ADNTRO Genetics to scale N-GENE, a genetic test…

2024-10-07

News & media 5

Published	Article
2025-10-13	ADNTRO Review: A Deep-Dive Into This Europe-Born DNA Test ↗ The Good Finds
2024-11-11	Cómo afecta el estrés a nuestra genética: entrevista al CEO de ADNTRO ↗ OKDiario
2024-10-04	Adntro Genetics to raise €1M with Bio&Tech Smart Capital in Spain ↗ Nordic 9
2024-01-23	ADNTRO awarded as Top Genomics Solutions Company in Europe-2023 ↗ AseBio
2024-01-10	Adntro o cómo conocerse mejor a través de un test genético en casa ↗ ReasonWhy